文献速递免疫规划

初次接种改良活病毒疫苗后,每年加强接种改良活病毒疫苗或改良活病毒/灭活病毒联合疫苗对牛病毒性腹泻病毒和牛疱疹病毒1型生殖保护效果的评估

Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
PubMed 文献 · Vaccine · 2017-01-19

研究将75头断奶肉用母牛分为三组:A组(n=30)配种前接种两剂改良活病毒疫苗并每年加强接种改良活病毒疫苗,B组(n=30)配种前接种两剂改良活病毒疫苗并每年加强接种含温度敏感改良活牛疱疹病毒1型和灭活牛病毒性腹泻病毒的联合疫苗,C组(n=15)接种生理盐水。在第二次妊娠期与6头持续感染牛共同饲养16天后,经静脉接种牛疱疹病毒1型。A组23头中流产3头、胎儿感染4头;B组22头中流产1头、胎儿感染0头;C组15头中流产11头、胎儿感染15头。

要点

  • 配种前接种两剂改良活病毒疫苗后每年加强接种联合疫苗可预防牛病毒性腹泻病毒和牛疱疹病毒1型暴露导致的胎儿丢失。
  • B组22头中流产1头、胎儿感染0头,优于C组15头中流产11头、胎儿感染15头。
  • A组23头中流产3头、胎儿感染4头,C组15头中流产11头、胎儿感染15头。

核心结论

  • 配种前给予两剂改良活病毒疫苗并每年使用联合疫苗加强接种,可预防因暴露于牛病毒性腹泻病毒和牛疱疹病毒1型导致的胎儿丢失。

研究设计与样本

  • 研究将75头断奶肉用母牛分配至A组(n=30;配种前两剂改良活病毒疫苗,每年加强接种改良活病毒疫苗)、B组(n=30;配种前两剂改良活病毒疫苗,每年加强接种联合疫苗)和C组(n=15;以生理盐水代替疫苗)。
  • 母牛在第0天(断奶)、第183天(配种前)、第366天(第一次妊娠)和第738天(第二次妊娠)接受处理。
  • 首次产犊后,初产母牛再次配种,并于第715天进行妊娠评估;此时A组24头(23头妊娠)、B组23头(22头妊娠)和C组15头(15头妊娠)与6头持续感染牛共同饲养16天。
  • 持续感染牛移除后99天,母牛经静脉接种牛疱疹病毒1型;所有胎儿和活产子代均检测牛病毒性腹泻病毒和牛疱疹病毒1型。

主要发现

  • 流产发生于A组23头中的3头、B组22头中的1头、C组15头中的11头。
  • 胎儿感染牛病毒性腹泻病毒或牛疱疹病毒1型发生于A组23头子代中的4头、B组22头子代中的0头、C组15头子代中的15头。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this study was to compare reproductive protection in cattle against bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) provided by annual revaccination with multivalent modified-live viral (MLV) vaccine or multivalent combination viral (CV) vaccine containing temperature-sensitive modified-live BoHV-1 and killed BVDV when MLV vaccines were given pre-breeding to nulliparous heifers. Seventy-five beef heifers were allocated into treatment groups A (n=30; two MLV doses pre-breeding, annual revaccination with MLV vaccine), B (n=30; two MLV doses pre-breeding, annual revaccination with CV vaccine) and C (n=15; saline in lieu of vaccine). Heifers were administered treatments on days 0 (weaning), 183 (pre-breeding), 366 (first gestation), and 738 (second gestation). After first calving, primiparous cows were bred, with pregnancy assessment on day 715. At that time, 24 group A heifers (23 pregnancies), 23 group B heifers (22 pregnancies), and 15 group C heifers (15 pregnancies) were commingled with six persistently infected (PI) cattle for 16days. Ninety-nine days after PI removal, cows were intravenously inoculated with BoHV-1. All fetuses and live offspring were assessed for BVDV and BoHV-1. Abortions occurred in 3/23 group A cows, 1/22 group B cows, and 11/15 group C cows. Fetal infection with BVDV or BoHV-1 occurred in 4/23 group A offspring, 0/22 group B offspring, and 15/15 group C offspring. This research demonstrates efficacy of administering two pre-breeding doses of MLV vaccine with annual revaccination using CV vaccine to prevent fetal loss due to exposure to BVDV and BoHV-1.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Walz PH, Givens MD, Rodning SP, et al. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine. Vaccine. 2017. PMID: 28111144. doi:10.1016/j.vaccine.2017.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。